Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07397377

prTMS as an Intervention for Bradykinesia in Parkinson's Disease

Led by Danish Research Centre for Magnetic Resonance · Updated on 2026-02-09

27

Participants Needed

1

Research Sites

71 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study investigates the use of patterned repetitive transcranial magnetic stimulation (prTMS) as an intervention for bradykinesia in Parkinson's Disease (PD). More specifically, the study aims to determine whether prTMS over the supplementary motor area (SMA) can reduce severity of bradykinesia in PD patients. This approach may open for more targeted and effective treatment of bradykinesia in PD.

CONDITIONS

Official Title

prTMS as an Intervention for Bradykinesia in Parkinson's Disease

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Above 18 years of age
  • Clinically established or probable Parkinson's Disease according to the Movement Disorder Society
  • Stable antiparkinsonian medicine for at least four weeks
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Psychiatric disorders
  • Current use of antipsychotic medication, Donepezil, or GABAergic agents (e.g., pregabalin, gabapentin)
  • Frequent benzodiazepine or opioid use more than once per week regularly
  • History of neurological disease other than Parkinson's Disease
  • Past or present mental illness
  • History of epilepsy or conditions increasing seizure risk with TMS
  • Close relatives with epilepsy or increased seizure risk
  • Contraindications for MRI or TMS
  • Female participants of childbearing age who are pregnant or not using contraception
  • Refusal to be informed about new health-related information or accidental findings during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

DRCMR

Hvidovre, Denmark, 2650

Actively Recruiting

Loading map...

Research Team

A

Ann-Charlot Rughaven, M.Sc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here